The latest generation of the device has shown improvements over the first generation, which demonstrated the potential to reduce disc bulges and avoid low back surgery. The therapy is an injection procedure. Testing of the device will continue for improved disc penetration and steering for optimal cell placement.
The device is currently patent-pending and is designed as a needle/catheter delivery system to inject cells directly into the annular tear that is causing the bulge or herniation.
More Articles on Spine Devices:
VG Innovations Receives Patent for Spinal Facet Fusion System
15 Spine Device Company Leadership Moves
LDR Receives FDA 510(k) Clearance for ROI-Lordic Cervical Cage
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.